Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 63
Healthy volunteers: yes

Brief summary:
This is a multiple dose study of LY3050258 in healthy men and postmenopausal women. This study will evaluate the safety and how well the body tolerates LY3050258. It will last approximately 14 weeks with a 2 week follow-up appointment after the last treatment with study drug.

Detailed description:

Arms:
arm 1: Daily dose of LY3050258 for 28 days: Cohort A 10 mg, Cohort B 30 mg, Cohort C 90 mg, Cohort D 180 mg and Cohort E 360 mg. arm 2: Daily dose of placebo matching LY3050258 for 28 days.

Interventions: intervention 1: LY3050258 intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: